Health economic modelling  

Modelling is an essential part of health economic analyses. It is a central tool for authorities, experts and payers to support decision-making regarding healthcare resource utilization. With the help of modelling, fragmented research data, observations, and experiences, as well as justified assumptions, are compiled into a synthesis that aims to anticipate and predict the impact of healthcare interventions on individuals, patient groups, healthcare and society. 

Modelling not only answers the decision maker’s question about the most likely outcome, but also the probability of extreme scenarios, as well as the credible range of results. In its most general form, modelling relates to the cost-effectiveness of an intervention. This means that the costs are examined together with the health benefits of the intervention. Another common target of modelling is the budget impact of an intervention. In this case, the focus is on the intervention’s impact on the use of resources. These can be even directly related to the intervention, or indirectly to the entire treatment path of a patient. 

Medaffcon has the ability to complete modelling projects from the localization of the customer’s ready global core models to the comprehensive construction of models from the beginning. We have been doing modelling for over 10 years, providing our customers with an effective tool to support decision making.  

 

The final outcomes of the projects are for example used in:

  • authority contexts
  • negotiations with decision-makers and payers at different levels
  • the support of sales and marketing, for example, in material production or tailor-made tools used in sales situations 

 

Read more about our interactive tools that combine health economic modelling, real world evidence and data science into one easy to use product.

Jarmo Hahl
”The purpose of modelling is to provide tools for the clients and decision makers for managing and predicting future uncertainty. Modelling provides information for decision-making and for discussions with public authorities and healthcare payers.”
Jarmo Hahl
Managing Director, Medaffcon Oy
Tatu Sainio
”Modeling enables the combination of information from multiple sources and thus the evaluation of effectiveness and cost-effectiveness. The analysis can be based on any kind of information, such as the results of clinical trials or real world data.”
Tatu Sainio
Sr. Health Economist & Access & HE Lead, Medaffcon Oy

Contact us for more information!

Tatu Sainio
Tatu Sainio
Sr. Health Economist
Access & HE Lead

Contact us

Our Health Economic Modelling Experts:

Tatu Sainio
Tatu Sainio
Sr. Health Economist
Access & HE Lead
Tatu Sainio

Tatu Sainio

Sr. Health Economist
Access & HE Lead
M.Sc. (Economics & Health Economics)

LinkedIn

Tatu joined Medaffcon in the fall of 2016. Tatu holds two master’s degrees, majoring in Marketing and Health Economics. Before joining Medaffcon, he worked in the pharmaceutical industry at Boehringer Ingelheim as an Account Manager. At Medaffcon, Tatu works mainly with health technology assessments and is the access & health economics team lead. Through his educational and professional background, Tatu has a wide range of expertise in the pharmaceutical industry and understands the needs of each function.

Tatu’s strength is his comprehensive understanding of the pharmaceutical industry and healthcare environment. Tatu is particularly interested in the possibility to turn data into understandable information to support healthcare decision-making.

“I love the hype around the utilization of real-world effectiveness and cost-effectiveness data. Now we need steps to include the data as a systematic part of the decision-making process, which allows the optimal allocation of resources”.


Jarmo Hahl
Jarmo Hahl
Managing Director
Jarmo Hahl

Jarmo Hahl

Managing Director
M.Sc. (Economics)

LinkedIn

Jarmo joined Medaffcon as a partner and CEO in 2010, having previously worked in various expert and management positions in pharma companies for eight years. Jarmo has a degree in economics and before entering the pharmaceutical industry, he held an office at the Turku School of Economics and also worked as a research fellow at Turku University Hospital.

Jarmo has strong expertise in new health technology innovations and how the demands and expectations of authorities, markets and customers are matched. He also brings to Medaffcon extensive experience in health economics and its applications in research and commercialization, as well as a broad understanding of the ever-changing operating environment.

“From an access point of view, the Finnish health technology market is constantly becoming more demanding and therefore also more attractive from my point of view. On the other hand, increasing demands to demonstrate the effectiveness and cost-effectiveness of healthcare are broadening the scope and opportunities for Medaffcon to be involved in the development of healthcare as a whole”.


Tanja Nieminen
Health Economist & Scientific Project Manager

Tanja Nieminen

Health Economist & Scientific Project Manager
M.Sc. (Health Economics & Economics)

LinkedIn

Tanja joined Medaffcon’s team in November 2016. Before that, she worked as a researcher at the National Institute for Health and Welfare. Tanja has also worked in an international research group, as a course instructor as well as in financial administration and customer service. She holds MSc degrees in both Health Economics and in the field of Economics and Business Administration.  

Tanja’s strengths include her educational and occupational background in health economics from Finland and abroad. Tanja has a special interest in utilizing real-world evidence data to be used in evaluations. “By utilizing data resources to support decision-making we become more aware of how scarce resources should be allocated”. 


Heini Honkanen
HEMAR Manager

Heini Honkanen

HEMAR Manager
M.Sc. (Health Economics)

LinkedIn

Heini joined Medaffcon’s Market Access team in May 2018. She has graduated in Health Economics from the University of Eastern Finland, and her master’s thesis discusses risk-sharing agreements in the pharmaceutical market.

Heini is interested in the changes occurring in the pharmaceutical and healthcare industries as well as in the possibilities of Health Economics in assessing the methods and economic resources in the field. Heini’s assets include her state-of-the-art theoretical knowledge in the field of Health Economics, combined with practice- and patient-oriented thinking.


Katerina Gävgänen
Katerina Gävgänen
Health Economist
Katerina Gävgänen

Katerina Gävgänen

Health Economist
M.A. (Economics) ja M.Sc. (Health Economics)

LinkedIn

Katerina joined Medaffcon in November 2020. She is internationally educated, holding two master’s degrees, a MA from the University of Aberdeen in Scotland and a MSc from the University of Rotterdam in the Netherlands, with a major in Economics and Health Economics, respectively.

Katerina brings to Medaffcon’s team strong theoretical expertise in health economics as well as an international perspective combined with patient and practice -oriented thinking.

She is particularly interested in the development of health economics methods and solutions at the international level, and their application in the local operating environment for the benefit of all stakeholders.